• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

ContextVision

Less than 1K followers

CONTX

Oslo Børs

Medical Equipment & Services

Health Care

Overview
Investor consensus

ContextVision is a medical technology company. The company specializes in image analysis and artificial intelligence. The company's products include advanced image enhancement software for ultrasound, MRI, X-ray and mammography. The software is used by hospitals and research institutes worldwide. The company was founded in 1983 and is headquartered in Stockholm.

Read more
Market cap
-
Turnover
-
Revenue
120.53M
EBIT %
0.38 %
P/E
-
Dividend yield-%
-
Financial calendar
All
Press releases
ShowingAll content types

Forum discussions
Yleistä ContextVision AB (CONTX) on lääketieteellisiin kuva-analyysiratkaisuihin (algoritmeihin) erikoistunut yritys, ja sen liiketoiminnan ydintä ovat kuvankäsittely, tekoäly ja lääketieteellinen diagnostiikka sekä erityisesti näihin liittyvät ohjelmistoratkaisut. Yritys on sanojensa...
11/27/2023, 1:16 PM
by timontti
71
I also asked AI about the competitive landscape. There are plenty of them
11/27/2023, 5:33 PM
by timontti
6
Annual report published https://www.contextvision.com/contextvision-publishes-annual-report-for-the-fiscal-year-2023/ P.S. You can also add Norwegian companies to your watchlist through the Inderes service, even if they don’t have analyst coverage. At least you’ll get notifications...
4/12/2024, 9:07 AM
by timontti
3
Read more on our forum
Financial calendar
27.8
2026

Interim report Q2'26

5.11
2026

Interim report Q3'26

18.2
2027

Annual report '26

Regulatory press release12.05.2026, 16.35

BULLETIN FROM THE ANNUAL GENERAL MEETING OF CONTEXTVISION AB (PUBL)

ContextVision
Regulatory press release11.05.2026, 17.34

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Regulatory press release08.05.2026, 08.00

ContextVision AB: Q1 interim report 2026 - Solid progress and disciplined execution in a stabilising market

ContextVision

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release29.04.2026, 17.14

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Regulatory press release24.04.2026, 08.00

Correction: Annual report financial calendar – Q1 interim report date

ContextVision
Regulatory press release20.04.2026, 17.16

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Regulatory press release09.04.2026, 18.38

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Regulatory press release08.04.2026, 08.00

ContextVision publishes annual report for the fiscal year 2025

ContextVision
Press release07.04.2026, 17.35

NOTICE TO THE ANNUAL GENERAL MEETING IN CONTEXTVISION AB (PUBL)

ContextVision
Regulatory press release07.04.2026, 07.30

ContextVision cancels market-making agreement

ContextVision
Regulatory press release26.03.2026, 17.20

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Press release26.03.2026, 13.00

ContextVision partners with BeamWorks to advance AI-powered quantitative ultrasound imaging solutions

ContextVision
Regulatory press release17.03.2026, 19.05

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Regulatory press release06.03.2026, 20.48

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Press release02.03.2026, 07.30

ContextVision announces changes to its management team and strengthens its technology leadership with appointment of new CTO

ContextVision
Regulatory press release25.02.2026, 17.04

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Regulatory press release19.02.2026, 10.02

CONTX: Financial calendar

ContextVision
Regulatory press release19.02.2026, 08.00

ContextVision AB: Year-end report 2025 – Substantial progress in transformation amid early signs of stabilization

ContextVision
Regulatory press release18.02.2026, 16.50

ContextVision announces extended share buy-back programme

ContextVision
Regulatory press release16.02.2026, 17.16

ContextVision AB: Transactions made under the buy-back programme

ContextVision